文献速递慢阻肺

慢阻肺诊断前急性加重史与后续急性加重风险

Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbations.
PubMed 文献 · Eur Respir J · 2024-10-03

基于Optimum Patient Care Research Database中73 189例新诊断慢阻肺患者,评估诊断前急性加重史、血嗜酸性粒细胞计数及是否启动维持治疗与诊断后一年内急性加重率的关系。未启动维持治疗者中,诊断前无、1次中度、≥2次中度、≥1次重度急性加重对应的后续中度急性加重率分别为0.34、0.59、1.18、1.21;血嗜酸性粒细胞计数未显著增加预测价值。

要点

  • 诊断前1次中度急性加重即增加诊断后急性加重风险。
  • 诊断前急性加重越频繁或越严重,后续风险越高。
  • 血嗜酸性粒细胞计数对预测后续急性加重无显著额外价值。

核心结论

  • 诊断前1次中度急性加重增加后续急性加重风险,更频繁或更严重的诊断前急性加重与更高风险相关。

研究设计与样本

  • 基于Optimum Patient Care Research Database的队列研究,纳入73 189例新诊断慢阻肺患者。

主要发现

  • 61.9%诊断前无急性加重,21.5%有1次中度,16.5%有≥2次中度,0.3%有≥1次重度。
  • 50%患者启动维持治疗。
  • 未启动维持治疗者诊断后一年中度急性加重率:无急性加重0.34(95%CI 0.33-0.35),1次中度0.59(95%CI 0.56-0.61),≥2次中度1.18(95%CI 1.14-1.23),≥1次重度1.21(95%CI 0.73-1.69)。
  • 启动维持治疗者结果相似。
  • 血嗜酸性粒细胞计数未显著增加对未来急性加重风险的预测。

临床怎么用

  • 新诊断慢阻肺时,应关注诊断前1年内急性加重史以评估后续急性加重风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prior exacerbation history is used to guide initial maintenance therapy in COPD; however, the recommendations were derived from patients already diagnosed and treated. METHODS: We assessed the rates of moderate (i.e. treated with antibiotics and/or systemic corticosteroids) and severe (i.e. hospitalised) exacerbations in the year following diagnosis in patients newly diagnosed with COPD according to their prior history of exacerbations, blood eosinophil count (BEC) and whether maintenance therapy was started. Data were extracted from the Optimum Patient Care Research Database. RESULTS: 73 189 patients were included. 61.9% had no exacerbations prior to diagnosis, 21.5% had 1 moderate, 16.5% had ≥2 moderate and 0.3% had ≥1 severe. 50% were started on maintenance therapy. In patients not started on maintenance therapy the rates of moderate exacerbations in the year after diagnosis in patients with no, 1 moderate, ≥2 moderate and ≥1 severe prior exacerbations were 0.34 (95% CI 0.33-0.35), 0.59 (95% CI 0.56-0.61), 1.18 (95% CI 1.14-1.23) and 1.21 (95% CI 0.73-1.69), respectively. Similar results were seen in patients started on maintenance therapy. BEC did not add significantly to the prediction of future exacerbation risk. CONCLUSIONS: A single moderate exacerbation in the year prior to diagnosis increases the risk of subsequent exacerbations, and more frequent or severe exacerbations prior to diagnosis are associated with a higher risk.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Halpin, Healey, Skinner, et al. Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbations. Eur Respir J. 2024. PMID: 39147410. doi:10.1183/13993003.02240-2023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。